Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025:2907:183-206.
doi: 10.1007/978-1-0716-4430-0_9.

Humanized Mouse Model of Graft-Versus-Host Disease Utilizing Nonirradiated NOD-scid-IL-2Rγnull Mice

Amal Elhage  1 , Chloe Sligar  2 , Debbie Watson  2 , Ronald Sluyter  2
Affiliations

Humanized Mouse Model of Graft-Versus-Host Disease Utilizing Nonirradiated NOD-scid-IL-2Rγnull Mice

Amal Elhage et al. Methods Mol Biol. 2025.

Abstract

Humanized mouse models of graft-versus-host disease (GVHD), involving the injection of human immune cells into immunodeficient mice, are firmly established and offer avenues for exploring pathways implicated in GVHD development and for testing therapeutics to prevent or treat this disease. NOD-scid-IL-2Rγnull (NSG) mice are a strain of immunodeficient mice commonly used to study GVHD. This chapter details methods relating to this model including human immune cell isolation, the injection of these human immune cells into nonirradiated NSG mice, monitoring the mice for signs of clinical GVHD (including weight loss), immunolabeling with anti-human and anti-mouse monoclonal antibodies of leukocytes isolated from the spleens, livers, and lungs of humanized mice, evaluating human cell engraftment and human and mouse immune cell subsets via flow cytometry and measuring serum cytokine concentrations using a multiplexed flow cytometric assay.

Keywords: Allogeneic hematopoietic stem cell transplantation; Cytokine; Flow cytometry; Human peripheral blood mononuclear cell; Humanized mouse model; Leukocyte; NSG mouse; Xenogeneic graft-versus-host disease.

PubMed Disclaimer

References

    1. Elfeky R, Lazareva A, Qasim W, Veys P (2019) Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources. Expert Rev Clin Immunol 15(7):735–751. https://doi.org/10.1080/1744666X.2019.1612746 - DOI - PubMed
    1. Hamilton BK (2021) Updates in chronic graft-versus-host disease. Hematology 2021(1):648–654. https://doi.org/10.1182/hematology.2021000301 - DOI - PubMed - PMC
    1. Malard F, Holler E, Sandmaier BM, Huang H, Mohty M (2023) Acute graft-versus-host disease. Nat Rev Dis Primers 9(1):27. https://doi.org/10.1038/s41572-023-00438-1 - DOI - PubMed
    1. Hülsdünker J, Zeiser R (2015) Insights into the pathogenesis of GvHD: what mice can teach us about man. Tissue Antigens 85(1):2–9. https://doi.org/10.1111/tan.12497 - DOI - PubMed
    1. Elhage A, Sligar C, Cuthbertson P, Watson D, Sluyter R (2022) Insights into mechanisms of graft-versus-host disease through humanised mouse models. Biosci Rep 42(9):BSR20211986. https://doi.org/10.1042/bsr20211986 - DOI - PubMed - PMC

Substances

LinkOut - more resources